ASTH vs USPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 31, 2026

ASTH

49.8
AI Score
VS
USPH Wins

USPH

51.5
AI Score

Investment Advisor Scores

ASTH

50score
Recommendation
HOLD

USPH

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ASTH USPH Winner
Revenue 1.94B 412.34M ASTH
Net Income 34.17M 14.94M ASTH
Net Margin 1.8% 3.6% USPH
Operating Income 62.85M 34.43M ASTH
ROE 4.1% 3.3% ASTH
ROA 1.5% 1.2% ASTH
Total Assets 2.28B 1.25B ASTH
Cash 400.79M 24.89M ASTH
Debt/Equity 1.06 0.48 USPH
Current Ratio 1.23 1.27 USPH

Relative Price Performance (Last 90 Days)

ASTH 1M: +4.6% · 3M: +1.7% USPH 1M: +3.9% · 3M: +10.3%

Current Technical Phase

ASTH

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.0%) with fading momentum, RSI 47

RSI (14): 46.5 · Price: $36.53

USPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.4% over 20 days), RSI 52

RSI (14): 52.4 · Price: $85.83

Fundamentals Snapshot

Metric ASTH USPH
Market Cap — —
Forward P/E 10.0 25.8
Trailing P/E 44.1 480.9
Revenue (TTM) — —
Revenue Growth 0.5% 0.1%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.1%
EPS 0.83 0.18
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, USPH is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.